Quitoxil is a clinically validated digital medical device (CE-marked) that supports smoking cessation through cognitive and behavioral therapy methods. The mobile application provides daily motivation, strategies for managing cravings, and relapse prevention, designed for use alongside healthcare professionals. It was developed from a protocol conceived by a leading European addictionology department (AP-HP Paul Brousse).
Funding
Funding not disclosed
Founders
Product
Problem
Smoking cessation is a difficult process with high relapse rates, and many smokers lack access to structured, evidence-based behavioral support outside of clinical settings. Traditional cessation programs often require frequent in-person visits, limiting their reach and making it hard for individuals to maintain motivation and receive validated strategies for managing cravings in daily life.
Solution
Quitoxil is a scientifically validated digital medical device that provides a structured, therapeutic companion for individuals during their smoking cessation journey. The application is based on Cognitive and Behavioral Therapies (CBT) and was designed under a protocol from a leading European addictionology department. It offers daily motivational support, validated strategies for managing cravings, and relapse prevention tools, all accessible directly from the user's smartphone. Quitoxil is intended to be prescribed by healthcare professionals such as tabacologists, pulmonologists, and general practitioners, and complements—rather than replaces—professional medical consultations.
Target Audience
Primary users are adult smokers seeking structured, professional-backed support to quit smoking, with the device prescribed by healthcare professionals including tabacologists, pulmonologists, and general practitioners.
Features
- CE-marked digital medical device, regulated and validated for use in a medical context
- Content based on Cognitive and Behavioral Therapies (CBT), with reference to Cochrane review evidence for combined pharmacotherapy and behavioral interventions
- Protocol designed by a leading European addictionology service (AP-HP Paul Brousse)
- Daily motivational support and structured strategies to manage tobacco cravings and prevent relapse
- Prescribed by tabacologists, pulmonologists, and general practitioners, integrating into the medical care pathway
- Distribution model directs pharmacists to order the device through major wholesalers (OCP & Phœnix)